Advisor Group Holdings, Inc. Emergent Bio Solutions Inc. Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 20,912 shares of EBS stock, worth $209,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,912

Previous 16,272 28.52%

Holding current value

$209,120

Previous $135,000 47.41%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$7.72 - $11.97 $35,820 - $55,540	4,640 Added 28.52%	20,912 $199,000
Q3 2024 Nov 13, 2024	SELL	$5.72 - $14.77 $4,198 - $10,841	-734 Reduced 4.32%	16,272 $135,000
Q2 2024 Aug 13, 2024	BUY	$1.86 - $6.98 $13,142 - $49,320	7,066 Added 71.09%	17,006 $115,000
Q1 2024 May 10, 2024	BUY	$1.5 - $3.41 $2,985 - $6,785	1,990 Added 25.03%	9,940 $25,000
Q4 2023 Feb 12, 2024	SELL	$1.82 - $3.16 $1,667 - $2,894	-916 Reduced 10.33%	7,950 $19,000
Q3 2023 Nov 13, 2023	BUY	$3.17 - $7.91 $10,140 - $25,304	3,199 Added 56.45%	8,866 $30,000
Q2 2023 Aug 10, 2023	BUY	$7.35 - $13.21 $24,262 - $43,606	3,301 Added 139.52%	5,667 $41,000
Q1 2023 May 12, 2023	SELL	$7.79 - $16.29 $7,704 - $16,110	-989 Reduced 29.48%	2,366 $24,000
Q4 2022 Feb 10, 2023	SELL	$11.0 - $21.45 $8,910 - $17,374	-810 Reduced 19.45%	3,355 $39,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $123,714 - $220,456	-6,158 Reduced 59.65%	4,165 $87,000
Q2 2022 Aug 10, 2022	SELL	$27.42 - $43.63 $17,411 - $27,705	-635 Reduced 5.79%	10,323 $321,000
Q1 2022 May 04, 2022	SELL	$36.48 - $52.22 $9,192 - $13,159	-252 Reduced 2.25%	10,958 $445,000
Q3 2021 Nov 05, 2021	SELL	$50.07 - $66.05 $339,674 - $448,083	-6,784 Reduced 37.7%	11,210 $563,000
Q2 2021 Aug 02, 2021	BUY	$56.61 - $80.46 $367,285 - $522,024	6,488 Added 56.39%	17,994 $1.14 Million
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $60,705 - $88,133	-704 Reduced 5.77%	11,506 $1.06 Million
Q4 2020 Feb 10, 2021	SELL	$79.17 - $111.47 $394,029 - $554,786	-4,977 Reduced 28.96%	12,210 $1.1 Million
Q3 2020 Nov 12, 2020	SELL	$81.91 - $134.94 $121,390 - $199,981	-1,482 Reduced 7.94%	17,187 $1.77 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $244,213 - $402,392	4,495 Added 31.71%	18,669 $1.48 Million
Q1 2020 May 18, 2020	BUY	$49.34 - $68.76 $699,345 - $974,604	14,174 New	14,174 $820,000

Others Institutions Holding EBS

# of Institutions

162

Shares Held

33.2M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $499M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Emergent Bio Solutions Inc. Transaction History